Diagnos Inc.
ADK.V
TSX
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -51.44% | -31.97% | -16.77% | -38.22% | -57.35% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -51.44% | -31.97% | -16.77% | -38.22% | -57.35% |
| Cost of Revenue | 16.05% | 9.84% | -42.99% | 33.77% | 56.86% |
| Gross Profit | -33.65% | -15.38% | 49.53% | -72.68% | -420.57% |
| SG&A Expenses | 61.04% | 56.66% | 2.64% | -11.27% | 16.89% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 45.54% | 36.52% | -11.80% | 1.17% | 28.14% |
| Operating Income | -52.99% | -40.16% | 11.44% | -5.41% | -51.44% |
| Income Before Tax | -45.57% | -33.73% | 6.47% | -11.30% | -57.22% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -45.57% | -33.73% | 6.47% | -11.30% | -57.22% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -45.57% | -33.73% | 6.47% | -11.30% | -57.22% |
| EBIT | -52.99% | -40.16% | 11.44% | -5.41% | -51.44% |
| EBITDA | -56.56% | -41.55% | 12.49% | -5.84% | -52.26% |
| EPS Basic | -12.20% | -18.18% | 15.19% | -3.90% | -49.09% |
| Normalized Basic EPS | -13.73% | -18.75% | 14.29% | -4.17% | -50.00% |
| EPS Diluted | -12.20% | -18.18% | 15.19% | -3.90% | -49.09% |
| Normalized Diluted EPS | -13.73% | -18.75% | 14.29% | -4.17% | -50.00% |
| Average Basic Shares Outstanding | 28.45% | 13.96% | 9.56% | 6.99% | 5.03% |
| Average Diluted Shares Outstanding | 28.45% | 13.96% | 9.56% | 6.99% | 5.03% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
